Suzhou Fushilai (China) Performance
| 301258 Stock | 27.94 0.05 0.18% |
On a scale of 0 to 100, Suzhou Fushilai holds a performance score of 13. The entity has a beta of -0.0702, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Suzhou Fushilai are expected to decrease at a much lower rate. During the bear market, Suzhou Fushilai is likely to outperform the market. Please check Suzhou Fushilai's total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Suzhou Fushilai's existing price patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Fushilai Pharmaceutical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Fushilai sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0215 | Payout Ratio 0.0291 | Forward Dividend Rate 0.6 | Ex Dividend Date 2024-06-12 |
| Begin Period Cash Flow | 259.7 M |
Suzhou |
Suzhou Fushilai Relative Risk vs. Return Landscape
If you would invest 2,032 in Suzhou Fushilai Pharmaceutical on September 13, 2024 and sell it today you would earn a total of 762.00 from holding Suzhou Fushilai Pharmaceutical or generate 37.5% return on investment over 90 days. Suzhou Fushilai Pharmaceutical is generating 0.6166% of daily returns and assumes 3.6824% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than Suzhou, and 88% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Suzhou Fushilai Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Suzhou Fushilai's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Suzhou Fushilai Pharmaceutical, and traders can use it to determine the average amount a Suzhou Fushilai's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1674
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 301258 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.68 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Suzhou Fushilai is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Suzhou Fushilai by adding it to a well-diversified portfolio.
Suzhou Fushilai Fundamentals Growth
Suzhou Stock prices reflect investors' perceptions of the future prospects and financial health of Suzhou Fushilai, and Suzhou Fushilai fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Suzhou Stock performance.
| Return On Equity | 0.0099 | ||||
| Return On Asset | -0.0028 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | (0.05) % | ||||
| Current Valuation | 1.18 B | ||||
| Shares Outstanding | 91.67 M | ||||
| Price To Book | 1.35 X | ||||
| Price To Sales | 6.31 X | ||||
| Revenue | 489.29 M | ||||
| Gross Profit | 253.31 M | ||||
| EBITDA | 49 M | ||||
| Net Income | 112.18 M | ||||
| Total Debt | 170.45 M | ||||
| Book Value Per Share | 20.77 X | ||||
| Cash Flow From Operations | 94.77 M | ||||
| Earnings Per Share | 0.20 X | ||||
| Total Asset | 2.12 B | ||||
| Retained Earnings | 663.54 M | ||||
About Suzhou Fushilai Performance
By analyzing Suzhou Fushilai's fundamental ratios, stakeholders can gain valuable insights into Suzhou Fushilai's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Suzhou Fushilai has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Suzhou Fushilai has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Suzhou Fushilai is entity of China. It is traded as Stock on SHE exchange.Things to note about Suzhou Fushilai Phar performance evaluation
Checking the ongoing alerts about Suzhou Fushilai for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Suzhou Fushilai Phar help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Suzhou Fushilai Phar appears to be risky and price may revert if volatility continues | |
| About 67.0% of the company shares are owned by insiders or employees |
- Analyzing Suzhou Fushilai's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Suzhou Fushilai's stock is overvalued or undervalued compared to its peers.
- Examining Suzhou Fushilai's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Suzhou Fushilai's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Suzhou Fushilai's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Suzhou Fushilai's stock. These opinions can provide insight into Suzhou Fushilai's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Suzhou Stock analysis
When running Suzhou Fushilai's price analysis, check to measure Suzhou Fushilai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Suzhou Fushilai is operating at the current time. Most of Suzhou Fushilai's value examination focuses on studying past and present price action to predict the probability of Suzhou Fushilai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Suzhou Fushilai's price. Additionally, you may evaluate how the addition of Suzhou Fushilai to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |